Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.
The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:
If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.
Antonia R. Sepulveda, MD PhD
The George Washington Univeristy Hospital
Lawrence J. Jennings, MD PhD
Northwestern Memorial Hospital
Jordan Laser, MD
North Shore - Long Island Jewish Health System
Michael Hadjisavas, PhD
Ester Stein, BS, MBA
Abbott Molecular Inc.
Board Member (2018-2019)
Annette S. Kim, MD, PhD
Brigham and Women's Hospital
Jonathan Baden, MS
Karen Weck, MD
Univeristy of North Carolina
Executive Director (Non-Voting)
Mary Steele Williams, MNA, MT(ASCP)SM